Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

For young people with type 1 diabetes, hybrid closed-loop insulin delivery does not affect the rate of severe hypoglycemia and is associated with an increased risk for diabetic ketoacidosis.

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

Eating behavior and consuming certain foods are associated with perceived pelvic floor disorders, according to a study recently published.

A presidential advisory has been published by the AHA regarding US government funding for the National Institutes of Health.

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

The FDA has filed the NDA submission for relacorilant to treat patients with Cushing syndrome (hypercortisolism).

For patients with obesity undergoing joint replacement, higher weight loss after initiating antiobesity medications within 1 year is associated with a lower risk for revision.

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.

Seniors who perform high-intensity interval training are less likely to experience chronic kidney disease (CKD).